课题基金 / 基金详情

Functional role of ATP-sensitive K^+ channel in vascular endothelial cells

Functional role of ATP-sensitive K^+ channel in vascular endothelial cells
血管内皮细胞中ATP敏感性K^通道的功能作用
批准号:
20590249
负责人:
NAKAYA Haruaki
金额:
$3.08万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2010

项目摘要

项目成果

NAKAYA Haruaki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
It has been reported that Prinzmetal-type angina pectoris is observed in Kir6.2-deficient or SUR2-deficient mice. In order to determine whether dysfunction of ATP-sensitive K^+ (KATP) channels in endothelial cells is involved in the development of vasospastic angina in Kir6.2-deficient or SUR2-deficient mice, we evaluated elecrophysiological responses to K^+ channel openers by using patch clamp techniques and gene expression by using real time PCR in endothelial cells. K^+ channel openers failed to affect the membrane potentials in vascular endothelial cells isolated from pulmonary tissues of wild type mouse and cultured mouse endothelial cells (UV cells). Ion channel genes related to KATP channels were hardly detected in these endothelial cells. In contrast, in mouse urinary bladder mRNA of Kir6.1 and SUR2B could be detected by RT-PCR. The K^+ channel opener pinacidil induced KATP current in visceral smooth muscle cells of wild type and Kir6.2-deficient mice, but not those of Kir6.1-deficient mice. These results suggest that KATP channel in vascular endothelial cells is unlikely to play an important role in the induction of vasospastic angina in mouse.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1172/jci39896
发表时间: 2010-06-01
期刊: JOURNAL OF CLINICAL INVESTIGATION
影响因子: 15.9
作者: [Ueda, Kazutaka, Takano, Hiroyuki, Komuro, Issei]
通讯作者: Komuro, Issei
Mechanism of pharmacological postconditioning by ghrelin after ischemia/reperfusion in rabbit hearts.
兔心脏缺血/再灌注后生长素释放肽的药理后处理机制。
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [原田新太郎, 稲村直樹, 西田洋文, 松本明郎, 中谷晴昭]
通讯作者: 中谷晴昭
グレリンのミトコンドリアATP感受性カリウムチャネルとホスファチジルイノシトール3キナーゼを介する心筋保護作用
线粒体 ATP 敏感钾通道和磷脂酰肌醇 3 激酶介导的生长素释放肽的心脏保护作用
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [稲村直樹, 西田洋文, 原田新太郎, 友野尚弘, 花開孝宏, 松本明郎, 中谷晴昭]
通讯作者: 中谷晴昭
Dose Anti-Inflammatory Action of Amiodarone Explain the High Efficancy in Patients With Heart Failure?
胺碘酮的剂量抗炎作用解释了心力衰竭患者的高疗效?
DOI: --
发表时间: 2009
期刊: Cir J. 73
影响因子: --
作者: [中山均, 趙晶, 吉栖正典, Nakaya H]
通讯作者: Nakaya H
68
    Assessment of role of Kir6.1 subunit (ATP-sensitive K+ channel) in J wave syndrome
    • 批准号:
      26460334
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.24万
    • 财政年份:
      2014
    • 负责人:
      NAKAYA Haruaki
    • 依托单位:
    Molecular and functional analysis of ATP-sensitive K^+ channel on the nuclear envelope
    • 批准号:
      18590232
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.57万
    • 财政年份:
      2006
    • 负责人:
      NAKAYA Haruaki
    • 依托单位:
    Role of Kir6.1 channels in cardiomyocytes clarified by Kir6.1-transgenic mice
    • 批准号:
      15390078
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.54万
    • 财政年份:
      2003
    • 负责人:
      NAKAYA Haruaki
    • 依托单位:
    Cellular mechanisms of cardioprotection by ischemic preconditioning : Functional study using Kir6.2- (Kir6.2^<-/->) and Kir6.1-deficient (Kir6.1^<-/->) mice
    • 批准号:
      13670080
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.62万
    • 财政年份:
      2001
    • 负责人:
      NAKAYA Haruaki
    • 依托单位:
    国内基金
    海外基金
    基于症状网络模型的血液系统肿瘤化疗患者核心症状群导向的精准护理干预策略的构建与验证研究
    • 批准号:
      2026JJ81902
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      左娟
    • 依托单位:
    血液微环境中 VraSR 与 BceSR 双组分系统的差异化激活调控金黄色葡萄球菌耐药异质性的机制研究
    老年痴呆症患者血液样本中 Aβ 寡聚体种类和结构的鉴定
    • 批准号:
      JCZRQT202600004
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    基于连续性血糖监测下糖尿病肾病血液透析患者血糖波动轨迹预测模型及血糖管理方案的构建与应用
    • 批准号:
      2026JJ81930
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      孙翠芳
    • 依托单位: